tradingkey.logo

Legend Biotech Corp

LEGN
31.700USD
-0.520-1.61%
Cierre 10/10, 16:00ETCotizaciones retrasadas 15 min
5.85BCap. mercado
PérdidaP/E TTM

Legend Biotech Corp

31.700
-0.520-1.61%

Más Datos de Legend Biotech Corp Compañía

Legend Biotech Corporation is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of cell therapies for oncology and other indications. Its lead product candidate, ciltacabtagene autoleucel (cilta-cel), referred to as LCAR- B38M, is an autologous chimeric antigen receptor (CAR-T) cell therapy that targets the B-cell maturation antigen (BCMA), which is a highly expressed protein in several hematologic malignancies, including multiple myeloma (MM). In addition to cilta-cel, the Company has a portfolio of earlier-stage autologous CAR-T product candidates targeting various cancers, including Non-Hodgkins Lymphoma, acute lymphoblastic leukemia, gastric cancer, esophageal cancer, pancreatic cancer, colorectal cancer, hepatocellular carcinoma, small cell lung cancer, and non-small cell lung cancer. It is also engaged in developing an allogeneic gamma delta CAR-T product candidate and an allogeneic CAR-NK product candidate targeting BCMA for MM.

Información de Legend Biotech Corp

Símbolo de cotizaciónLEGN
Nombre de la empresaLegend Biotech Corp
Fecha de salida a bolsaJun 04, 2020
Director ejecutivoDr. Ying Huang, Ph.D.
Número de empleados2600
Tipo de seguridadDepository Receipt
Fin del año fiscalJun 04
Dirección2101 Cottontail Lane
CiudadSOMERSET
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal08873
Teléfono17328505598
Sitio Webhttps://investors.legendbiotech.com/
Símbolo de cotizaciónLEGN
Fecha de salida a bolsaJun 04, 2020
Director ejecutivoDr. Ying Huang, Ph.D.

Ejecutivos de Legend Biotech Corp

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Ye (Sally) Wang
Ms. Ye (Sally) Wang
Director
Director
84.32K
--
Dr. Li Mao
Dr. Li Mao
Independent Director
Independent Director
7.62K
--
Dr. Li Zhu, Ph.D.
Dr. Li Zhu, Ph.D.
Director
Director
4.20K
--
Mr. Xiaohui (Darren) Ji
Mr. Xiaohui (Darren) Ji
Independent Director
Independent Director
--
--
Ms. Jessie Yeung
Ms. Jessie Yeung
Director
Director
--
--
Dr. Peter Salovey, Ph.D.
Dr. Peter Salovey, Ph.D.
Independent Director
Independent Director
--
--
Mr. Wai Man (Philip) Yau, CPA
Mr. Wai Man (Philip) Yau, CPA
Independent Director
Independent Director
--
--
Dr. Ying Huang, Ph.D.
Dr. Ying Huang, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
-100.00%
Mr. Tomas J. (Tom) Heyman, Jr.
Mr. Tomas J. (Tom) Heyman, Jr.
Independent Director
Independent Director
--
--
Dr. Fangliang (Frank) Zhang, Ph.D.
Dr. Fangliang (Frank) Zhang, Ph.D.
Chairman of the Board
Chairman of the Board
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Ye (Sally) Wang
Ms. Ye (Sally) Wang
Director
Director
84.32K
--
Dr. Li Mao
Dr. Li Mao
Independent Director
Independent Director
7.62K
--
Dr. Li Zhu, Ph.D.
Dr. Li Zhu, Ph.D.
Director
Director
4.20K
--
Mr. Xiaohui (Darren) Ji
Mr. Xiaohui (Darren) Ji
Independent Director
Independent Director
--
--
Ms. Jessie Yeung
Ms. Jessie Yeung
Director
Director
--
--
Dr. Peter Salovey, Ph.D.
Dr. Peter Salovey, Ph.D.
Independent Director
Independent Director
--
--

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2025Q2
FY2025Q1
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
Sin datos
Por regiónUSD
Nombre
Ganancia
Proporción
United States
194.60M
76.30%
Europe
40.50M
15.88%
China
19.95M
7.82%
Por negocio
Por región
Sin datos

Estadísticas de accionistas

Actualizado: vie., 26 de sep
Actualizado: vie., 26 de sep
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Fidelity Management & Research Company LLC
12.53%
Westfield Capital Management Company, L.P.
3.51%
HHLR Advisors, Ltd.
3.36%
Suvretta Capital Management, LLC
2.04%
Deerfield Management Company, L.P.
1.60%
Otro
76.95%
Accionistas
Accionistas
Proporción
Fidelity Management & Research Company LLC
12.53%
Westfield Capital Management Company, L.P.
3.51%
HHLR Advisors, Ltd.
3.36%
Suvretta Capital Management, LLC
2.04%
Deerfield Management Company, L.P.
1.60%
Otro
76.95%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
22.83%
Investment Advisor/Hedge Fund
13.71%
Hedge Fund
8.80%
Corporation
1.22%
Research Firm
1.12%
Venture Capital
0.59%
Pension Fund
0.37%
Bank and Trust
0.31%
Sovereign Wealth Fund
0.20%
Otro
50.86%

Participación institucional

Actualizado: dom., 5 de oct
Actualizado: dom., 5 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
544
88.77M
48.09%
-19.63M
2025Q2
545
89.45M
48.54%
-25.68M
2025Q1
566
91.15M
49.68%
-26.78M
2024Q4
546
104.37M
56.89%
-4.12M
2024Q3
521
96.19M
52.43%
-11.10M
2024Q2
501
96.66M
52.77%
-1.31M
2024Q1
490
91.55M
50.22%
-3.47M
2023Q4
482
91.08M
50.06%
-4.11M
2023Q3
468
90.50M
49.93%
-2.81M
2023Q2
459
88.99M
49.23%
+9.84M
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Fidelity Management & Research Company LLC
23.13M
12.53%
+11.87M
+105.49%
Jun 30, 2025
Westfield Capital Management Company, L.P.
6.47M
3.51%
-445.02K
-6.43%
Jun 30, 2025
HHLR Advisors, Ltd.
6.20M
3.36%
+218.70K
+3.65%
Jun 30, 2025
Suvretta Capital Management, LLC
3.77M
2.04%
+24.04K
+0.64%
Jun 30, 2025
Deerfield Management Company, L.P.
2.96M
1.6%
+1.22M
+69.90%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
2.85M
1.55%
-255.88K
-8.23%
Jun 30, 2025
Braidwell LP
2.54M
1.38%
-435.85K
-14.64%
Jun 30, 2025
Fidelity Institutional Asset Management
2.54M
1.38%
+593.12K
+30.44%
Jun 30, 2025
Genscript Biotech Corp
2.25M
1.22%
--
--
Dec 31, 2024
Artisan Partners Limited Partnership
2.12M
1.15%
+990.50K
+87.52%
Jun 30, 2025
Ver más

ETFs relacionados

Actualizado: lun., 6 de oct
Actualizado: lun., 6 de oct
Nombre
Proporción
Harbor Health Care ETF
5.9%
Matthews Emerging Markets Discovery Active ETF
4.6%
Matthews Emerging Markets Sustainable Future Active ETF
4.43%
Global X Genomics & Biotechnology ETF
3.69%
Tema Oncology ETF
2.56%
Virtus LifeSci Biotech Products ETF
1.53%
KraneShares MSCI All China Health Care Index ETF
1.25%
Main Thematic Innovation ETF
0.46%
iShares Biotechnology ETF
0.39%
Invesco Nasdaq Biotechnology ETF
0.29%
Ver más
Harbor Health Care ETF
Proporción5.9%
Matthews Emerging Markets Discovery Active ETF
Proporción4.6%
Matthews Emerging Markets Sustainable Future Active ETF
Proporción4.43%
Global X Genomics & Biotechnology ETF
Proporción3.69%
Tema Oncology ETF
Proporción2.56%
Virtus LifeSci Biotech Products ETF
Proporción1.53%
KraneShares MSCI All China Health Care Index ETF
Proporción1.25%
Main Thematic Innovation ETF
Proporción0.46%
iShares Biotechnology ETF
Proporción0.39%
Invesco Nasdaq Biotechnology ETF
Proporción0.29%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
KeyAI